SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-023918
Filing Date
2024-03-01
Accepted
2024-03-01 16:29:56
Documents
12
Period of Report
2024-02-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K lyra-20240226.htm   iXBRL 8-K 34426
  Complete submission text file 0000950170-24-023918.txt   147289

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lyra-20240226.xsd EX-101.SCH 24868
13 EXTRACTED XBRL INSTANCE DOCUMENT lyra-20240226_htm.xml XML 4698
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 24710381
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)